Liver Diseases Therapeutics Market Size, Share and Growth 2015 - PowerPoint PPT Presentation

Loading...

PPT – Liver Diseases Therapeutics Market Size, Share and Growth 2015 PowerPoint presentation | free to download - id: 7ecccf-ZGI0Z



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Liver Diseases Therapeutics Market Size, Share and Growth 2015

Description:

Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis. Hepatitis is the largest segment among these diseases, of which hepatitis C is the biggest and fastest growing segment. – PowerPoint PPT presentation

Number of Views:9

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Liver Diseases Therapeutics Market Size, Share and Growth 2015


1
www.hexareports.com
v
Global Liver Diseases Therapeutics Market Size
and Share, Growth, Market Price, Analysis,
Forecast and Overview 2015 - 2019
Category Pharmaceutical
2
Report Overview
  • Liver diseases are of different types such as
    hepatitis, liver cancer, non-alcoholic fatty
    liver disease, and liver cirrhosis. Hepatitis is
    the largest segment among these diseases, of
    which hepatitis C is the biggest and fastest
    growing segment. The liver diseases caused by
    viral infections, alcoholism, obesity, diabetes,
    among many other reasons.
  • Some of the diseases are not curable such as
    liver cirrhosis or non-alcoholic fatty liver
    disease, and are usually not diagnosed early.
    This leads to the substantial damage of the
    liver, which proves to be life-threatening. Some
    types of hepatitis are preventable or treatable
    by using vaccines and indicated drugs.
  • Technavio's analysts forecast the global liver
    diseases therapeutics market to grow at a CAGR of
    15.61 over the period 2014-2019.

www.hexareports.com
3
Covered in this report
  • This report covers the present scenario and the
    growth prospects of the global liver diseases
    therapeutics market for 2015-2019. To calculate
    the market size, the report considers revenue
    generated from the sales of various off-label and
    branded drugs and the expected launch of drug
    candidates intended to be used in the treatment
    of liver diseases.
  • Based on disease indication, the market is
    segmented as follows
  • Non-alcoholic fatty liver disease (includes
    non-alcoholic steatohepatitis)
  • Liver cirrhosis
  • Liver cancer
  • Hepatitis (Hepatitis A, B, and C)
  • This report includes a discussion of the market
    in the following three regions
  • Americas The major countries focused in the
    Americas are the US, Canada, Mexico, and Brazil
  • EMEA The major countries in this region are the
    UK, Germany, Italy, France, Spain and Middle
    Easternand African countries such as Israel,
    South Africa, Egypt, Sudan, Kuwait, Saudi Arabia,
    Qatar, and the UAE
  • APAC The major countries in this region are
    Japan, China, Australia, Singapore, South Korea,
    and India.

www.hexareports.com
4
Other prominent vendors
  • AbbVie
  • Achillion Pharmaceuticals
  • Advinus
  • Angion Biomedica
  • AstraZeneca
  • Bayer
  • BiOrion
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celsion
  • Conatus
  • Digna Biotech
  • Dynavax Technologies
  • Eli Lilly
  • Galectin Therapeutics
  • LG Life Sciences

www.hexareports.com
5
Key market
  • Key market driver
  • Increased prevalence of liver diseases
  • For a full, detailed list, view our report
  • Key market challenge
  • Multiple patent expiries
  • For a full, detailed list, view our report
  • Key market trend
  • Growing public awareness
  • For a full, detailed list, view our report
  • Key questions answered in this report
  • What will the market size be in 2019 and what
    will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats
    faced by the key vendors?

www.hexareports.com
6
Thank You!
For More Details
http//www.hexareports.com/report/global-liver-dis
eases-therapeutics-market/details
Stay With US
Global Head Quarters Felton Office Plaza, 6265
Highway 9, Felton, California, 95018, ?United
States.
E-mail sales_at_hexareports.com
Telephone Direct
1-800-489-3075
About PowerShow.com